Per-protocol analysis of the ZINC trial for HIV disease among alcohol users

Per-protocol analysis of the ZINC trial for HIV disease among alcohol users

Abstract Background The Zinc for INflammation and Chronic disease in HIV (ZINC) trial randomized person who live with HIV (PLWH) who engage in heavy drinking to either daily zinc supplementation or placebo. The primary outcome was change in the Veterans Aging Cohort Study (VACS) index, a predictor o...

Full description

Bibliographic Details
Main Authors: Sara Lodi, Matthew Freiberg, Natalia Gnatienko, Elena Blokhina, Tatiana Yaroslavtseva, Evgeny Krupitsky, Eleanor Murray, Jeffrey H. Samet, Debbie M. Cheng
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Trials
Subjects:
Zinc
Alcohol abuse
HIV
Per-protocol
Inverse probability weighting
Online Access:https://doi.org/10.1186/s13063-021-05178-9

Internet

https://doi.org/10.1186/s13063-021-05178-9

Similar Items